VIVAZEN Applauds Federal Action to Ban Dangerous Synthetic 7-OH and Reaffirms Support for Science-Driven Kratom Reform
'As someone who has experienced the benefits of kratom firsthand, I've long been an advocate for ensuring that this important botanical is safely and responsibly available to customers. This is a milestone for consumer safety, scientific integrity, and public health,' said Steve Curtis, CEO of VIVAZEN. 'We fully support the FDA and HHS in taking this courageous action in drawing a clear line between the naturally occurring alkaloids in kratom and the synthetic opioid-like compound 7-hydroxymitragynine. These are not the same substance, and conflating them has harmed consumers and held back meaningful botanical research. We further urge the agency to use the full extent of its power to immediately remove 7-OH products from store shelves.'
7-hydroxymitragynine, often produced by chemically oxidizing kratom's primary alkaloid, mitragynine using industrial oxidants like bleach and pool shock, can be present at potent and dangerous concentrations in adulterated products that falsely claim to be 'kratom.' In contrast, natural kratom leaves contain only trace amounts of 7-OH, if any, and have been safely used by millions of Americans.
VIVAZEN has long been at the forefront of science-first kratom formulation, ensuring all of its products are rigorously tested, contain no synthetic alkaloids, and comply with evolving state and federal safety standards.
'What's happening now is the beginning of regulatory maturity,' said Curtis. 'FDA's own data now confirms the safety and tolerability of mitragynine at levels up to 140 mg. NIH-funded studies also show kratom enhances, rather than suppresses, respiratory activity, exactly the opposite of synthetic 7-OH. This bifurcation is necessary and overdue.'
VIVAZEN encourages the following actions by HHS and FDA:
'Consumers deserve clean, transparent, and trustworthy products,' Curtis added. 'At VIVAZEN, we've built our brand on safety and integrity, and we welcome this renewed focus on scientific truth. We look forward to working with policymakers and regulators to protect the future of kratom and the millions who rely on it.'
About VIVAZEN
For over a decade, VIVAZEN has delivered trusted, high-quality botanical supplements that provide people with functional wellness without compromise. Rooted in centuries of herbal wisdom and backed by modern innovation, VIVAZEN is a functional, feel-good alternative for those who want to live—and feel—on their own terms. Join the millions who trust VIVAZEN to Feel Great™ naturally, and visit feelgreatbotanics.com, opens new tab.
Media Contact
Paloma Lehfeldtpress@vivazen.com
###
SOURCE: VIVAZEN
Copyright 2025 EZ Newswire
See release on EZ Newswire
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economist
8 minutes ago
- Economist
RFK Jr's attack on mRNA technology endangers the world
DURING THE covid-19 pandemic new vaccines were rolled out with unprecedented speed. The fastest to arrive were jabs built from molecules of messenger RNA (mRNA) designed to teach the body how to fight off the disease-causing virus. By late 2021, mRNA vaccines had saved an estimated 7.7m lives globally, including most of the 3m Americans whom the Commonwealth Fund, an American health-care charity, estimates were saved by vaccines before 2023.
Daily Mail
8 minutes ago
- Daily Mail
Experts warn of new 'epidemic' as deadly fungus spreads faster than ever in US
Thousands of Americans have contracted an incurable fungus on the West Coast being dubbed a new 'epidemic'. Valley Fever, which got its name because a majority of cases are found in Arizona and California, is a deadly lung infection that kills one in 100 people that contract it. In just 25 years, cases have climbed more than 1,200 percent in California. For the first six months of 2025, there were more than 5,500 provisional cases reported in the state. Health experts say if cases continue at the same rate, they will surpass last year's high of nearly 12,500. In Arizona, there were more than 14,000 reported cases of Valley Fever in 2024, up from 10,990 cases in 2023, marking an uptick of more than 27 percent. Nationwide, Valley Fever cases are now at a record high and set to reach almost 30,000 for 2025. Valley Fever is caused by the fungus coccidioides, which releases spores into the air when soil is disturbed. Health experts are warning people to avoid dusty outdoor environments as they could breathe in the coccidioides spores. The number of Valley Fever cases peaked for the first time in a decade in 2021. The 20,970 recorded instances were the most on record for a single year since the last peak in 2011. Instances declined in 2022 but picked back up last year, and experts are concerned over an expected surge of the fungus in the coming decades. The CDC estimates Valley Fever could infect more than half a million Americans each year in the future. The agency said that due to rising temperatures across the globe, the endemic region of the disease will spread north to include dry western areas. Other experts fear that it could be endemic in 17 states by 2100. California Department of Public Health director Dr Erica Pan said: 'California had a record year for Valley fever in 2024 and, so far, case counts are high in 2025. Valley fever is a serious illness that's here to stay in California. 'We want to remind Californians, travelers to California, and their healthcare providers to watch for signs and symptoms of Valley fever to help detect it early.' There is no person-to-person transmission of the disease, for which there is currently no preventative vaccine. Valley Fever can often resolve on its own without treatment. For more severe or persistent cases, antifungal medications are used to manage symptoms and prevent the infection from worsening or spreading. Experts warn that Valley Fever can often be missed by doctors or misdiagnosed as pneumonia as it presents similar symptoms such as fatigue, cough, fever, aching muscles and breathlessness. Other symptoms include night sweats, joint aches and a red rash, usually on the legs but occasionally on the chest, arms and back. As the disease is often underdiagnosed due to mild symptoms, the CDC estimates that the true burden is around 206,000 to 360,000 cases per year - 10 to 18 times more than reported. But up to 10 percent of infections become severe and take months to recover from. In these cases, known as disseminated coccidioidomycosis, the disease can spread through the bloodstream to other parts of the body, including the brain, skin and liver. If it infects the membranes and fluid around the brain it can cause life-threatening meningitis. To prevent the disease from reaching advanced stages, Dr Pan advises: 'If you have been sick with symptoms like cough, fever, trouble breathing, and tiredness for more than seven to ten days, please talk to a healthcare provider about Valley fever, especially if you've been outdoors in dusty air in the Central Valley or Central Coast regions.' On average, there were approximately 200 coccidioidomycosis-associated deaths each year from 1999 to 2021. Research suggests the rise and spread of Valley fever may be linked to changes in climate. Wet winters after droughts help the fungus grow, and dry, windy weather in the following summer and fall can help the fungus get into the air. Shaun Yang, the director for molecular microbiology and pathogen genomics at the UCLA Department of Pathology and Laboratory Medicine, told SFGate: 'I think climate change is the main reason to explain this type of dramatic explosion. 'I don't think anything else can explain this type of phenomenon. This kind of very wet and dry pattern definitely is perfect for this fungus to grow.' There is no proven treatment for Valley Fever and patients are usually prescribed rest and given therapies to manage symptoms. Doctors may prescribe antifungal medications, but there is no evidence from clinical trials that show these treatments are effective - and antifungal drugs come with the potential for serious side effects. In 1996, the Valley Fever Center for Excellence at the University of Arizona, was established in order to address the problems caused by the coccidioides fungus. Two-thirds of all Valley Fever infections in the US occur in Arizona, mostly in the urban areas surrounding Phoenix and Tucson. Last year, the University of Arizona Valley Fever Center for Excellence secured $33 million from the National Institute of Health to pursue a vaccine. Its director, Dr John Galgiani, helped develop one for dogs THAT is still undergoing licensing for commercial marketing. But it is hoped the VACCINE could translate to humans. 'I've been thinking about a human vaccine all along but taking this through the dog is really a very useful step to show proof of the concept, making the idea of taking it to humans that much more attractive,' Mr Galgiani said.
Metro
an hour ago
- Metro
Toxic vapor kills fifth person in New York City
A fifth person has succumbed to a deadly vapor that has crept up on New York City. Legionnaires' disease, a kind of pneumonia that spreads from toxic water vapor, has also infected 108 people since the outbreak began at the end of July, according to the New York City Health Department on Monday. The latest death was 'under investigation for some time and our team was able to confirm this death as part of the cluster today', stated the department. Twelve cooling centers in Central Harlem tested positive for Legionella bacteria, which grows in warm water and can be transmitted when the liquid becomes steam. All the affected centers were drained and disinfected on Friday. The disease was airborne at health centers, residences, various businesses and a college in Harlem, which is a neighborhood in Upper Manhattan. They include NYC Health + Hospitals Harlem Hospital, NYC Health Department Central Harlem Sexual Health Clinic, The New York Hotel Trades Council Harlem Health Center, The New York Hotel Trades Council Harlem Health Center, Harlem Center Condo, Commonwealth Local Development, and the CUNY City College Marshak Science Building, among others. The number of cases is growing but the rate has declined, a sign that it has likely been contained. Authorities are still investigating which cooling tower was the source of the outbreak. Details on the people who died and those battling the disease have not been released. High-profile attorneys Ben Crump and Reverand Al Sharpton said they plan to announce a lawsuit on Wednesday against a construction company they believe caused the outbreak. Legionnaires' disease symptoms include a fever reaching 104 Fahrenheit or higher, muscle aches and severe headaches. People can die from lung failure, kidney failure, decreased blood flow to the organs, or a septic shock. About 1,000 Americans die of Legionnaires' disease per year and 8,000 to 10,000 become infected. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: Brain-eating amoeba with 97% fatality rate found in Australian drinking water MORE: Map shows Hurricane Erin along US East Coast threatening to isolate barrier islands MORE: Food influencers narrowly escape death after car crashes into restaurant table mid-review
